Progression-free survival estimates are shaped by specific censoring rules: Implications for PFS as an endpoint in cancer randomized trials
Vadim Lesan, Timothée Olivier, Vinay Prasad
Topics & Concepts
Censoring (clinical trials)MedicineClinical trialClinical endpointIbrutinibFood and drug administrationProgression-free survivalInternal medicineOncologyClinical OncologyOverall survivalCancerPathologyPharmacologyLeukemiaChronic lymphocytic leukemiaChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentAdvanced Breast Cancer Therapies